Angie Hignite, PA
Plastic and Reconstructive Surgery · Tulsa, OKNPI 1336388792
Payments from drug & device makers
What this record shows
AbbVie accounts for 67.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $2,902 and has fallen 87.5% since, to $363 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in OK, where the typical reported total is $3,788.
Across 37 payments — averaging $96.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Stryker$571
- Baxter Healthcare$139
- Vertex$112
- Smith+Nephew$81
- AstraZeneca$45
- plus $226 from 10 others
What the payments were for
- Travel & lodging$2,03557%
- Food & beverage$1,54843%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $2,410 |
| Stryker | 1 | $571 |
| Baxter Healthcare | 4 | $139 |
| Vertex | 4 | $112 |
| Smith+Nephew | 3 | $81 |
| AstraZeneca | 2 | $45 |
| Organogenesis Inc. | 1 | $43 |
| W. L. Gore & Associates, Inc. | 1 | $30 |
| Acera Surgical, Inc. | 1 | $25 |
| Coopersurgical, Inc. | 1 | $24 |
| Kerecis Limited | 2 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Conmed Corporation | 1 | $20 |
| KCI USA, Inc. | 1 | $14 |
| Solventum Corporation | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,583 in reported general payments places this provider in the 45th percentile of 22 plastic and reconstructive surgery providers in Oklahoma.
See all plastic and reconstructive surgery providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 22 | $474 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Tulsa
- Archibald MillerTulsa$415K
- Stephen PaulsenTulsa$27K
- Greg RatliffTulsa$13K
- Scott NewbroughTulsa$4K
- Shaw TangTulsa$3K
- Laurie DuckettTulsa$3K
- Scott KreitzbergTulsa$3K
- Brent RubisTulsa$2K
- Brenda SchieselTulsa$2K
- John TedescoTulsa$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.